A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
About
Brief Summary
This protocol is to ensure consistent long-term follow-up for delayed safety events in participants who received A2 Bio gene therapy (GT) products.
Study Type
Eligibility
Gender
Healthy Volunteers
Minimum Age
Maximum Age
Inclusion Criteria:
- Received any amount of A2 Bio GT product on a previous A2 Bio interventional study
- Able to provide written informed consent for this long-term follow-up study
- Able to comply with study requirements
Exclusion Criteria:
1. There are no specific exclusion criteria for this study
Join this Trial
Enrolling by Invitation
These studies are not open to everyone who meets the eligibility criteria, but
only to people in that particular population, who are specifically invited to participate.
Share:
Study Stats
Protocol No.
26-0672
Category
Colorectal Cancer
Lung Cancer
Pancreatic Cancer
Stomach Cancer
Principal Investigator
Contact
- Aricka Fayton
Location
- UCLA Santa Monica